Tag: healthcare

Dermatology Society Urges New Tests for Stubborn Eczema
Trial Briefs

Dermatology Society Urges New Tests for Stubborn Eczema

Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors...

14/09/2026
Early Kidney Disease Diagnosis Rates Stagnant
Trial Briefs

Early Kidney Disease Diagnosis Rates Stagnant

Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.

11/09/2026
Diagnostic guidelines for suspected epilepsy take shape
Vaccine News

Diagnostic guidelines for suspected epilepsy take shape

New diagnostic guidelines for suspected epilepsy focus on ruling out seizures and classifying focal or...

09/09/2026
Zorevunersen Shows Adaptive Gains in Dravet Patients
Clinic Moves

Zorevunersen Shows Adaptive Gains in Dravet Patients

Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a...

08/09/2026
Valbenazine Improves Quality of Life in Tardive Dyskinesia
Trial Briefs

Valbenazine Improves Quality of Life in Tardive Dyskinesia

New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.

07/09/2026
Dual Therapy Shifts SMA Treatment Landscape
Trial Briefs

Dual Therapy Shifts SMA Treatment Landscape

Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments...

04/09/2026
New Treatment Slows Brain Tumor Regrowth
Drug Approvals

New Treatment Slows Brain Tumor Regrowth

GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...

01/09/2026
New Guidelines for Stroke Rehabilitation Released
Clinic Moves

New Guidelines for Stroke Rehabilitation Released

Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with...

31/08/2026
Sarkey Highlights Oveporexton Impact on Type 1 Narcolepsy
Trial Briefs

Sarkey Highlights Oveporexton Impact on Type 1 Narcolepsy

FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn...

30/08/2026
FDA Week: New CMT Trial Framework and Brain Injury Medicine Focus
Drug Approvals

FDA Week: New CMT Trial Framework and Brain Injury Medicine Focus

FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...

29/08/2026